A diversified portfolio
Ackermans & van Haaren concentrates on a limited number of strategic participations with an important potential for growth.
AvH is listed on Euronext Brussels and is included in the BEL20 index, the BEL ESG index and the European DJ Stoxx 600 index.
Key financial highlights
At an economic level, the AvH group represented in 2025 a pro forma turnover of 7.7 billion euros and employed 24,931 people through its share in the participations. The group concentrates on a limited number of strategic participations with an important potential for growth.
Net result (2025)
€ 593 m
Shareholders’ equity (31 Dec. 2025)
€ 5,701 m
Net cash (31 Dec. 2025)
€ 429 m
Recent press releases
View allGrowth Capital
April 30, 2026
Confo Therapeutics Announces Phase 2 Clinical Trial Initiation by Lilly for Peripheral Pain Candidate, CFTX-1554
Growth Capital
April 29, 2026
Biotalys Reports Full-Year 2025 Financial Results and Business Highlights
Growth Capital
April 27, 2026